Skip to content

A study of various medications used in patients with bipolar depression like mood stabilizers, antipsychotics and antidepressants

A prescription audit of mood stabilizers, antipsychotics and antidepressants in clinically stable patients with bipolar depression: a cross sectional study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/07/071455
Enrollment
93
Registered
2024-07-29
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F313- Bipolar disorder, current episodedepressed, mild or moderate severity

Interventions

Intervention1: NIL: NIL

Sponsors

Dr Nithin Rajendran
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patients will be adults (aged 18 years and above) diagnosed with bipolar depression as per standardized diagnostic criteria (e.g., DSM-5). 2)Patients who will be medically stable. 3)Patients of either sex 4)Participants actively receiving treatment for bipolar depression during the study period. 5)Patients who will be accompanied by reliable informants. 6)Patients and informants who give written informed consent and are willing participate in the study.

Exclusion criteria

Exclusion criteria: 1)Individuals with acute manic or depressive episodes, as the focus is on clinically stable patients. 2)Those with a history of recent hospitalizations or significant disruptions in treatment adherence, as these factors may act as confounders. 3)Patients with comorbid psychiatric conditions that significantly impact the assessment of bipolar depression prescription audit. 4)Participants unable or unwilling to provide informed consent. 5)Patients having insufficient data or records. 6)Pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
Prescription audit with respect to WHO core drug use indicators- 1.Prescribing indicators 2.Patient-care indicators 3.Health facility indicatorsTimepoint: 2 Years

Secondary

MeasureTime frame
Prevalence of polypharmacyTimepoint: 2 Years

Countries

India

Contacts

Public ContactDr Nithin Rajendran

Government Medical College

drneetusharma1975@gmail.com9417075783

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026